MARKET

LNSR

LNSR

Lensar Inc
NASDAQ
5.88
+0.08
+1.38%
After Hours: 5.75 -0.13 -2.21% 19:33 05/20 EDT
OPEN
5.79
PREV CLOSE
5.80
HIGH
5.92
LOW
5.78
VOLUME
51.88K
TURNOVER
--
52 WEEK HIGH
14.20
52 WEEK LOW
5.06
MARKET CAP
71.17M
P/E (TTM)
3.305
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LNSR last week (0511-0515)?
Weekly Report · 2d ago
Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)
TipRanks · 05/11 13:30
Weekly Report: what happened at LNSR last week (0504-0508)?
Weekly Report · 05/11 10:16
LENSAR signals 2027 as “really, really good” year as it rebuilds distributor orders after Alcon deal termination
Seeking Alpha · 05/08 15:32
LENSAR publishes corporate presentation on ALLY robotic laser cataract surgery system
PUBT · 05/08 13:59
LENSAR GAAP EPS of $0.00 misses by $0.18, revenue of $13.4M in-line
Seeking Alpha · 05/08 11:21
LENSAR Q1 revenue falls 5%, hurt by merger uncertainty; recurring revenue rises 9%
Reuters · 05/08 11:15
LENSAR Q1 FY26 swings to net income of $36.3 million; revenue falls 5% to $13.4 million
PUBT · 05/08 11:02
More
About LNSR
LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. The Company's product portfolio includes the LENSAR Laser System and the ALLY Robotic Cataract Laser System and their associated consumable components. It has developed its ALLY System as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating artificial intelligence into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing its advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite. ALLY allows the surgeon to switch between cataract laser and the surgeon’s existing phacoemulsification device without moving patients from room-to-room. ALLY includes its proprietary Streamline software technology.

Webull offers LENSAR Inc stock information, including NASDAQ: LNSR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNSR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNSR stock methods without spending real money on the virtual paper trading platform.